Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis

Hanlu Li1, Tianju Li1

  • 1Department of Infectious Diseases, Beibei Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Summary

Intermittent fasting (IF) shows greater reductions in weight, BMI, and LDL-C compared to continuous energy restriction (CER) for metabolic dysfunction-associated steatotic liver disease (MASLD). IF may offer benefits for liver fat, but more research is needed.